Table 4.
Study 2: Efficacy of ProHeart 12 compared to Heartgard Plus or Interceptor Plus against the JYD-34 heartworm strain: Day 165 inoculation, adult heartworm AG and MF results
| Treatment | Dosage | Days of treatment | Number of infected dogsa, b | No. dogs positive for adult heartworm AGc | No. dogs positive for MF | ||
|---|---|---|---|---|---|---|---|
| Day 331 (day 166 PI) | Day 360 (day 195 PI) |
Day 331 (day 166 PI) |
Day 360 (day 195 PI) | ||||
| Negative control | NA | 0 | 6 of 6 | 6 of 6d | 6 of 6e | 0 of 6 | 5 of 6 |
| ProHeart 12 | 0.5 mg/kg moxidectinf | 0 | 4 of 6 | 0 of 6g | 1 of 6h | 0 of 6 | 0 of 6 |
| Heartgard Plus |
Min. of 6 µg/kg ivermectini |
0, 30, 60, 90, 120, 150, 180, 210, 240, 270, 300, 330 | 6 of 6 | 6 of 6j | 6 of 6 | 0 of 6 | 5 of 6 |
| Interceptor Plus |
Min. of 0.5 mg/kg milbemycin oximek |
0, 30, 60, 90, 120, 150, 180, 210, 240, 270, 300, 330 | 6 of 6 | 6 of 6l | 6 of 6m | 0 of 6 | 5 of 6 |
aEach dog was inoculated with 50 D. immitis third-stage larvae (JYD-34 strain) on day 165
bAll dogs were necropsied for recovery of adult D. immitis on day 360 (195 days PI; 30 days after the last treatment with Heartgard Plus and Interceptor Plus)
cDiroCHEK
d Two of six dogs positive only after heat treatment; positive on both DiroCHEK and Snap4DX
eOne of six dogs positive only after heat treatment; positive on both DiroCHEK and Snap4DX
f ProHeart 12 (moxidectin extended-release injectable suspension) administered according to commercial label directions which resulted in a point administration of 0.5 mg/kg of moxidectin to each dog
gAll six of the dogs remained Ag-negative after samples were heat treated
hOne dog with a single male worm was slightly positive only after heat treatment; positive on both DiroCHEK and Snap4DX
iHeartgard Plus (ivermectin + pyrantel) administered according to commercial label directions which resulted in administration of 6.5 to 11.5 µg/kg of ivermectin
jThree of six dogs positive only after heat treatment; positive on both DiroCHEK and Snap4DX
kInterceptor Plus (milbemycin oxime + praziquantel) administered according to commercial label directions which resulted in administration of 0.51 to 1.1 mg/kg milbemycin oxime
lFive of six dogs positive only after heat treatment; positive on both DiroCHEK and Snap4DX
mOne of six dogs positive only after heat treatment; positive on both DiroCHEK and Snap4DX